TickerFacts.

Aprea Therapeutics, Inc. (APRE): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-20, first reflected in a filing dated 2023-03-30. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

6.54M
Year ended 2025-12-31
2019-12-31: 6.00M2020-12-31: 1.06M2021-12-31: 1.06M2022-12-31: 1.66M2023-12-31: 3.62M2024-12-31: 5.51M2025-12-31: 6.54M6.54M
2019-12-31 Weighted Average Diluted Shares (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-316.54M+18.7%2026-03-16, From 2025-01-01
2024-12-315.51Mn/c2026-03-16, From 2024-01-01
2023-12-313.62M+118.3%2025-03-25, From 2023-01-01
2022-12-311.66M+55.7%2024-03-26, From 2022-01-01
2021-12-311.06M+0.7%2024-03-26, From 2021-01-01
2020-12-311.06Mn/c2023-03-30, From 2020-01-01
2019-12-316.00Mn/a2022-03-15, From 2019-01-01